Register-based studies of cardiovascular disease

Scandinavian Journal of Public Health

Volumn 39, Issue 7, 2011, Pages 165-169

  Abildstrøm, Steen Z ^a,b,c   Torp Pedersen, Christian ^d   Madsen, Mette ^e  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c Danish Heart Register ^*  (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cardiovascular disease; epidemiology; pharmacological treatment

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

CARDIOVASCULAR DISEASE; DENMARK; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MORTALITY; PRESCRIPTION; REGISTER; REVIEW; RISK FACTOR; SOCIOECONOMICS; STANDARD; STATISTICS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOVASCULAR DISEASES; DENMARK; DRUG PRESCRIPTIONS; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; MYOCARDIAL INFARCTION; PATIENT ADMISSION; REGISTRIES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 79960766991     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494810396559     Document Type: Article

References (26)

1. Bjerregaard LJ, Joensen AM, Dethlefsen C., Jensen MK, Johnsen SP, Tjonneland A., et al. Fish intake and acute coronary syndrome. Eur Heart J 2010 ; 31: 29-34.
2. Hansen TW, Staessen JA, Zhang H., Torp-Pedersen C., Rasmussen S., Thijs L., et al. Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hypertens 2007 ; 20: 483-91. (Pubitemid 46678710)
3. Hvelplund A., Galatius S., Madsen M., Rasmussen JN, Rasmussen S., Madsen JK, et al. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. Eur Heart J 2010 ; 31 (6). 684-90.
4. Jensen MK, Chiuve SE, Rimm EB, Dethlefsen C., Tjonneland A., Joensen AM, et al. Obesity, behavioral lifestyle factors, and risk of acute coronary events. Circulation 2008 ; 117: 3062-9.
5. Jeppesen J., Hein HO, Suadicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998 ; 97: 1029-36.
6. Jorgensen T., Ladelund S., Borch-Johnsen K., Pisinger C., Schrader AM, Thomsen T., et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Prev Med 2009 ; 48: 242-6.
7. Lauritzen T., Jensen MS, Thomsen JL, Christensen B., Engberg M. Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scand J Public Health 2008 ; 36: 650-61.
8. Mogelvang R., Søgaard P., Pedersen SA, Olsen NT, Marott JL, Schnohr P., et al. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 2009 ; 119: 2679-85.
9. Nielsen T., Burgdorf KS, Grarup N., Borch-Johnsen K., Hansen T., Jorgensen T., et al. The KCNMB1 Glu65Lys polymorphism associates with reduced systolic and diastolic blood pressure in the Inter99 study of 5729 Danes. J Hypertens 2008 ; 26: 2142-6.
10. Sehestedt T., Jeppesen J., Hansen TW, Rasmussen S., Wachtell K., Ibsen H., et al. Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J Hypertens 2009 ; 27: 2351-7.
11. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000 ; 21: 1502-13.
12. Madsen M., Davidsen M., Rasmussen S., Abildstrøm SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003 ; 56: 124-30. (Pubitemid 36315938)
13. Pell JP, Simpson E., Rodger JC, Finlayson A., Clark D., Anderson J., et al. Impact of changing diagnostic criteria on incidence, management, and outcome of acute myocardial infarction: retrospective cohort study. BMJ 2003 ; 326: 134-5. (Pubitemid 36135567)
14. Abildstrom SZ, Rasmussen S., Madsen M. Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed. Eur Heart J 2005 ; 26: 990-5. (Pubitemid 40695030)
15. Pedersen CB The Danish Civil Registration System. Scand J Public Health 2011 ; 39 (Suppl 7). 22-5.
16. Euroaspire. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997 ; 18: 1569-82.
17. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001 ; 22: 554-72.
18. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011 ; 39 (Suppl 7). 38-41.
19. Gislason GH, Abildstrøm SZ, Rasmussen JN, Rasmussen S., Buch P., Gustafsson I., et al. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J 2005 ; 39: 42-9. (Pubitemid 40662735)
20. Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsboll N., Buch P., Friberg J., et al. Long-term compliance with beta-blockers, angiotensin- converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 2006 ; 27: 1153-8.
21. Rasmussen JN, Gislason GH, Abildstrøm SZ, Rasmussen S., Gustafsson I., Buch P., et al. Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol 2005 ; 60: 150-8. (Pubitemid 41075900)
22. Rasmussen JN, Gislason GH, Rasmussen S., Abildstrøm SZ, Schramm TK, Kober L., et al. Use of statins and beta-blockers after acute myocardial infarction according to income and education. J Epidemiol Community Health 2007 ; 61: 1091-7. (Pubitemid 350207367)
23. Lokkegaard E., Lidegaard O., Moller LN, Agger C., Andreasen AH, Jorgensen T. Hormone replacement therapy in Denmark, 1995-2004. Acta Obstet Gynecol Scand 2007 ; 86: 1342-51. (Pubitemid 350034537)
24. Fosbol EL, Gislason GH, Jacobsen S., Abildstrøm SZ, Hansen ML, Schramm TK, et al. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf 2008 ; 17: 822-33.
25. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000 ; 343: 1520-8.
26. Fosbol EL, Gislason GH, Jacobsen S., Folke F., Hansen ML, Schramm TK, et al. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther 2009 ; 85: 190-7.